HRT Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
1,265,535
-98,042
-7% -$175K 0.01% 1733
2025
Q4
$2.55M Buy
+1,363,577
New +$2.62M 0.01% 1142
2025
Q3
Sell
-106,280
Closed -$131K 3518
2025
Q2
$131K Sell
106,280
-37,563
-26% -$43.4K ﹤0.01% 2159
2025
Q1
$169K Buy
+143,843
New +$221K ﹤0.01% 2059
2023
Q4
Sell
-134,188
Closed -$1.12M 2906
2023
Q3
$1.12M Buy
134,188
+109,475
+443% +$1.25M 0.01% 904
2023
Q2
$328K Buy
+24,713
New +$300K ﹤0.01% 1574
2022
Q4
Sell
-151,070
Closed -$876K 2997
2022
Q3
$876K Buy
+151,070
New +$867K 0.01% 1018
2022
Q2
Sell
-129,950
Closed -$1.18M 3562
2022
Q1
$1.18M Buy
+129,950
New +$1.5M 0.01% 916
2021
Q4
Sell
-41,001
Closed -$1.05M 3882
2021
Q3
$1.05M Buy
+41,001
New +$1.21M 0.01% 1225
2020
Q4
Sell
-240,493
Closed -$2.37M 2315
2020
Q3
$2.37M Buy
+240,493
New +$1.38M 0.08% 197
2019
Q2
Sell
-24,477
Closed -$176K 877
2019
Q1
$176K Buy
+24,477
New +$177K 0.03% 410

Other funds holding PACB